A new non-pharmacological vacuum therapy for female sexual dysfunction
A new non-pharmacological vacuum therapy for female sexual dysfunction
复制标题
DOI：
10.1080/713846826
复制
发表时间：
2001-10-01
影响因子：
2.5
通讯作者：
Goldstein, I
中科院分区：
文献类型：
--
作者：
Billups, KL;Berman, L;Goldstein, I
虽然女性性功能障碍(FSD)影响着40%的美国女性，但目前还没有FDA批准的药物tberapy。无Eros-CTD(TM)(阴蒂治疗设备，UroMetrics，Inc.，St.Paul，Ain)疗法是FDA批准上市的第一种FSD疗法。阴蒂充血被认为对女性的性唤起和整体的性满足起着重要的作用。EROS-CTD是一种由电池供电的小型设备，旨在增强阴蒂充血，增加流向阴蒂的血液，并最终提高患有FSD的女性的唤醒能力。本研究的目的是评估Eros-CTD对性唤起(生殖器感觉、阴道润滑、达到性高潮的能力和性满意度)在正常志愿者和FSD女性中的有效性。
Although Female Sexual Dysfunction (FSD) affects 40% of American women, there is no FDA-approved pharmaceutical tberapy. no EROS-CTD (TM) (Clitoral Therapy Device, UroMetrics, Inc., St. Paul, AIN) treatment is the first FDA cleared-to-market therapy for FSD. Clitoral engorgement is believed to play an important role in female sexual arousal and overall sexual satisfaction. The EROS-CTD is a small, battery-powered device designed to enhance clitoral engorgement, increase blood flow to the clitoris, and ultimately improve arousal in women with FSD. The objective of this study tvas to assess The effectiveness of the EROS-CTD on sexual arousal (genital sensation, vaginal lubrication, ability to reach orgasm, and sexual satisfaction) in normal volunteers and women with FSD.